Abstracts
Páginas: 2 (328 palabras)
Publicado: 7 de junio de 2012
NKF 2009 Spring Clinical Meetings Abstracts 185
DIABETIC TYPE 2 NEPHROPATHY (DN), PROTEINURIA (P) & HYPERTENSION (HTN) MANAGEMENT: IM RESIDENTS (R) VSFACULTY (F) IN ACADEMIC CLINICS. Allan Schwartz, Syed Ashraf, Veeraish Chauhan, Arif Jan, Drexel UCoM, Phila, PA, USA. This 2 yr QI project audited 1614 diabeticpts’ electronic medical records: R=637,F=977 from Jan’07-Nov’08 for P; P:CR {microalb=30-299mcg/mg Creatinine(Cr)& overt P=>300mcg/mgCr, eGFR using MDRD;systolic BP (SBP)& diastolic BP (DBP); number & class of anti HTN meds. 80% of pts were AA. Female were 67% in R, 80% in F clinic. P tested by:(1) UA once/yr:R=31% vs F=61%(2) P:CR R=50% vs F=70%. In R clinic 25% had microalb, 9% overt. In F clinic 21% had microalb, 8% overt. eGFR for micro DN was 83ml/min for R &78ml/min for F. eGFR for overt DN was 61ml/min for R & 44ml/min F. BP was the same for micro & overt P pts at R & F clinics (See Table). Anti HTN meds formicro DN= 2.78 R & 2.95 F, for overt DN= 3.24 by both R & F. Residents Faculty p-Value BP Micro132/79 Micro137/78 p=0.053 NS Overt141/80 Overt139/83 p=0.081NS ACEI Micro 36% Micro 33.3% p=0.011 Overt 42.9% Overt 27.6% p=0.085 NS ARB Micro 20.3% Micro 38.9% p=0.011 Overt 9.5% Overt 20.7% p=0.085 NS B blocker 40.8%32.0% p=0.004 R tested P & P:CR insufficiently. Micro/Overt P prevalence was equal in R & F clinics. R reduced P:CR greater than F. eGFR was higher formicro & overt DN in R clinic. ACEI were used > by R, ARBs were used > by F. B blockers R>F; diuretic & CCB R = F. Total anti HTN meds for R=F. Goal BP of
DIABETIC TYPE 2 NEPHROPATHY (DN), PROTEINURIA (P) & HYPERTENSION (HTN) MANAGEMENT: IM RESIDENTS (R) VSFACULTY (F) IN ACADEMIC CLINICS. Allan Schwartz, Syed Ashraf, Veeraish Chauhan, Arif Jan, Drexel UCoM, Phila, PA, USA. This 2 yr QI project audited 1614 diabeticpts’ electronic medical records: R=637,F=977 from Jan’07-Nov’08 for P; P:CR {microalb=30-299mcg/mg Creatinine(Cr)& overt P=>300mcg/mgCr, eGFR using MDRD;systolic BP (SBP)& diastolic BP (DBP); number & class of anti HTN meds. 80% of pts were AA. Female were 67% in R, 80% in F clinic. P tested by:(1) UA once/yr:R=31% vs F=61%(2) P:CR R=50% vs F=70%. In R clinic 25% had microalb, 9% overt. In F clinic 21% had microalb, 8% overt. eGFR for micro DN was 83ml/min for R &78ml/min for F. eGFR for overt DN was 61ml/min for R & 44ml/min F. BP was the same for micro & overt P pts at R & F clinics (See Table). Anti HTN meds formicro DN= 2.78 R & 2.95 F, for overt DN= 3.24 by both R & F. Residents Faculty p-Value BP Micro132/79 Micro137/78 p=0.053 NS Overt141/80 Overt139/83 p=0.081NS ACEI Micro 36% Micro 33.3% p=0.011 Overt 42.9% Overt 27.6% p=0.085 NS ARB Micro 20.3% Micro 38.9% p=0.011 Overt 9.5% Overt 20.7% p=0.085 NS B blocker 40.8%32.0% p=0.004 R tested P & P:CR insufficiently. Micro/Overt P prevalence was equal in R & F clinics. R reduced P:CR greater than F. eGFR was higher formicro & overt DN in R clinic. ACEI were used > by R, ARBs were used > by F. B blockers R>F; diuretic & CCB R = F. Total anti HTN meds for R=F. Goal BP of
Leer documento completo
Regístrate para leer el documento completo.